BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
May 8, 2002
View Archived Issues
GenOway Enters Drug Target Deal, Plans $5.4M Financing
PARIS - GenOway SA signed a nonexclusive agreement with the French pharmaceutical company Servier for the in vivo validation of a number of therapeutic gene targets. (BioWorld International
Read More
EU Advisers Support Stem Cell Research, Cautious On Patents
Read More
Reprogramming Technique Raises Hopes Of Adult Skin Cell Therapy
Read More
Screentec Signals Discovery Ambitions With Name Change
Read More
Other News To Note
Read More
MMI Raises £1.6M In Placement To Finance Start-Ups, Incubators
Read More
Proteome Sciences’ Data Show Sensitivity, Specificity In Test
Read More
Personal Chemistry Purchases ESyTech To Extend Platform
Read More
Cerep Completes Drug Target Validation Under 1999 BMS Deal
Read More